Company Filing History:
1 out of 39 
1 out of 1 
1 out of 35 
Years Active: 2011-2023
Title: Innovations of Rocco Jamie Rotello: Pioneering Research in Antibody Therapeutics
Introduction: Rocco Jamie Rotello, an accomplished inventor based in Lebanon, Ohio, has made significant contributions to the field of biotechnology. With a portfolio of four patents, he stands out as a leading figure in the development of therapeutic antibodies targeting human protein tyrosine phosphatase beta (HPTPβ). His work continues to impact research and applications in the medical field.
Latest Patents: Among his latest innovations, Rocco has developed antibodies and antigen binding fragments that specifically bind to human protein tyrosine phosphatase beta. These patents highlight both the composition of these antibodies and their potential uses. The focus on HPTPβ demonstrates his commitment to addressing critical health challenges through targeted therapeutic strategies.
Career Highlights: Throughout his career, Rocco has demonstrated his expertise while working with reputable companies such as Warner Chilcott Company, LLC and Aeripo Therapeutics Inc. His experiences in these organizations have allowed him to refine his skills and contribute to groundbreaking research initiatives.
Collaborations: Rocco has collaborated with notable professionals in his field, including Michael Glenn Davis and Kevin Gene Peters. These collaborations have enriched his work, fostering the exchange of ideas and expertise that often leads to innovative solutions in biotechnology.
Conclusion: Rocco Jamie Rotello remains a prominent inventor in the biotechnology landscape, with a focus on developing antibodies that have the potential to transform therapeutic practices. His dedication to research and innovation positions him as an influential figure in the ongoing quest for medical advancements.